ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0165

Hypothyroidism Is Associated with Worse Clinical and Utilization Outcomes After Primary Total Knee Arthroplasty

Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

Meeting: ACR Convergence 2023

Keywords: Administrative Data, Arthroplasty, Health Services Research, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0155–0175) Health Services Research Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Limited information is available regarding how medical comorbidities affect the outcomes of total knee arthroplasty (TKA). The association of medical comorbidities with post-TKA outcomes may vary by the primary underlying cause leading to TKA. We evaluated the association of hypothyroidism with TKA outcomes, overall and by the primary diagnoses categorized as knee osteoarthritis (OA), avascular necrosis (AVN), fractures, and inflammatory arthritis including rheumatoid arthritis (RA), or spondylarthritis (SpA) (ankylosing spondylitis (AS), psoriatic arthritis (PsA)).

Methods: We identified all patients in the 2019 national inpatient sample (NIS) that received primary TKA and stratified them based on primary diagnoses. The population was stratified into knee OA (N=529,621), traumatic arthritis (N=7,690) and inflammatory arthritis (RA, AS, or PsA; N=1,175) and other diagnoses. Hypothyroidism was determined using secondary diagnoses. We assessed clinical and healthcare utilization outcomes as endpoints using multivariable-adjusted regression analyses adjusted for race, age, sex, hospital bed size, census region and teaching status.

Results: Total cohort population was 563,381 Mean age was 67.18 years, 61.6% were female, and mean length of stay was 2.12 days.

Overall, hypothyroidism was associated with increased adjusted odds of non-routine discharge, blood transfusion, acute renal failure (ARF), and anemia (p≤0.037 each). In the knee OA cohort, hypothyroidism was associated with increased adjusted odds of non-routine discharge, ARF, and anemia (p≤0.025 each). Hypothyroidism was not associated with any complications or adverse patient outcomes in the traumatic or inflammatory arthritis cohorts.

Conclusion: Hypothyroidism impacts TKA outcomes, particularly in patients with knee OA. These findings hold crucial implications for patient care and guidance for orthopedic surgeons, emphasizing the necessity for thorough preoperative evaluations and care plans. By better understanding these risks, we can enhance patient outcomes and streamline surgical protocols.

Supporting image 1

Supporting image 2


Disclosures: S. Chandrupatla: None; K. Rumalla: None; J. Singh: Other, 2, 6, 11, 11, 12, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc., Seres Therapeutics, Tonix, Charlotte’s Web, 12, Atai life sciences, kintara therapeutics, Intelligent Biosolutions, Acumen pharmaceutical, TPT Global Tech, Vaxart pharmaceuticals, Atyu biopharma, 12, speaker’s bureau of Simply Speaking, other, 12, received institutional research support from Zimmer Biomet Holdings. JAS received food and beverage payments from Intuitive Surgical Inc./Philips Elec, Other, 12, Schipher, Crealta/Horizon, Medisys, Fidia, PK Med, Two labs Inc., Adept Field Solutions, Clinical Care options, Clearview healthcare partners, Putnam.

To cite this abstract in AMA style:

Chandrupatla S, Rumalla K, Singh J. Hypothyroidism Is Associated with Worse Clinical and Utilization Outcomes After Primary Total Knee Arthroplasty [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/hypothyroidism-is-associated-with-worse-clinical-and-utilization-outcomes-after-primary-total-knee-arthroplasty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypothyroidism-is-associated-with-worse-clinical-and-utilization-outcomes-after-primary-total-knee-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology